DOCSLIB.ORG

CPEB4 Function in Macrophages

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

CPEB4 function in macrophages Clara Suñer Navarro Aquesta tesi doctoral està subjecta a la llicència Reconeixement 4.0. Espanya de Creative Commons. Esta tesis doctoral está sujeta a la licencia Reconocimiento 4.0. España de Creative Commons. This doctoral thesis is licensed under the Creative Commons Attribution 4.0. Spain License. Universitat de Barcelona Facultat de Farmàcia i Ciències de l’Alimentació IRB Barcelona Programa de Doctorat en Biomedicina CPEB4 function in macrophages Aquesta tesi ha estat realitzada per la Clara Suñer Navarro sota la direcció del Dr. Raúl Méndez de la Iglesia, a l’Institut de Recerca Biomèdica de Barcelona (IRB Barcelona). Es presenta aquesta memòria per optar al títol de doctora per la Universitat de Barcelona en el Programa de Doctorat en Biomedicina. Raúl Méndez de la Iglesia Antonio Zorzano Olarte Clara Suñer Navarro Director de tesi Tutor de tesi Doctoranda Barcelona 2018 Para los cuatro. “Not only to be receiver, but also to be provider” Buddhist proverb Preface What is the meaning of life? Throughout history, great efforts have been made trying to understand which is the significance of living or existence. Philosophical, scientific, theological and metaphysical approaches have proposed multiple answers to questions such as “Why are we here?”, “What is life all about?”, or “What is the purpose of existence?”. Scientific contributions have focused primarily on describing empirical facts about the universe, exploring the context and parameters concerning what life is and aiming to describe how it works. Though life definition is still a challenge, from the biologist point of view lifeforms are self-organizing systems that regulate their internal environments as to maintain this organized state, also known as homeostasis, and reproduce to continue life over multiple generations. Importantly, homeostasis maintenance needs the capacity to sense and adapt to the external environment. Throughout this thesis, we will focus on a specific subset of mechanisms developed to respond to a certain stimulus. These mechanisms, if successful, return life to its homeostatic state but, upon failure, may lead to life- threating conditions. I am afraid we will not provide a new answer to the question “What is the meaning of life?”, however we will further describe its complexity and fragility and, one could extrapolate from that, how precious life is. 9 INDEX Index PREFACE ____________________________________________ 9 ABBREVIATIONS ____________________________________ 21 ABSTRACT ___________________________________________ 27 INTRODUCTION ____________________________________ 31 1. Regulation of protein synthesis ......................................................... 33 1.1. pre-mRNA processing ......................................................................................34 1.2. Mature mRNA structure ..................................................................................37 1.3. mRNA translation .............................................................................................38 1.3.1. Translation initiation .................................................................................38 1.3.1.1. Regulation of translation initiation ................................................40 1.3.2. Translation elongation ..............................................................................42 1.3.3. Translation termination and ribosome recycling .................................43 1.4. mRNA localization ............................................................................................44 1.5. mRNA decay ......................................................................................................46 1.5.1. Basal mRNA decay ..............................................................................46 1.5.2. Quality control (QC) decay ................................................................46 1.6. mRNA deadenylation .......................................................................................47 1.7. Cytoplasmic Polyadenylation ...........................................................................49 1.7.1. Cytoplasmic Polyadenylation Element Binding Proteins ...................50 1.7.2. Cytoplasmic Polyadenylation Elements (CPEs) ...................................51 1.7.3. Regulation of CPEBs activity .................................................................52 1.7.4. CPEBs biological function ......................................................................54 1.7.5. Mechanisms regulating CPEBs expression ...........................................56 2. The Innate immune system ............................................................... 57 2.1. The mononuclear phagocytic system (MPS) .................................................59 2.2. Macrophage function during an inflammatory response ............................60 2.3. Macrophage activation by LPS ........................................................................61 13 2.4. TLR4 signalling pathway ..................................................................................62 BOX 1. MAPK signalling cascades ....................................................................63 2.4.1. MyD88-dependent signal transduction .................................................64 2.4.2. TRIF-dependent signal transduction .....................................................64 2.4.3. Role of MAPK in LPS response: p38, ERK, JNK .............................65 2.4.4. NF- κB .......................................................................................................66 2.4.5. Autocrine loops in LPS response ...........................................................67 2.5. Inflammation resolution: TLR4 and NF-κB negative Regulators .............68 2.6. Post-transcriptional control during the LPS response .................................71 2.6.1. mRNA decay during the LPS response .................................................71 2.6.2. Translational regulation during the LPS response ...............................74 2.6.3. CPEBs in LPS response ...........................................................................75 OBJECTIVES _________________________________________ 77 RESULTS _____________________________________________ 81 1. CPEB4 is upregulated upon LPS stimulation in Macrophages .....................83 2. CPEB4 mRNA stability is regulated during the LPS response via p38a-HuR-TTP .....................................................................................................85 3. CPEB4 is phosphorylated during the LPS response ......................................90 4. Defining CPEB4 function during the late LPS response in BMDMs.......... 92 4.1. CPEB4 regulates negative feedback inhibitors of the LPS response ..92 BOX 2. Revisiting CPEs definition ...........................................................94 4.2. Assessing CPEB4 function in BMDMs by ribosome profiling ............97 4.3. Distinct behaviours of CPEB4 targets in Cpeb4KO BMDMs ..............103 4.4. Interplay between CPEB4 and TTP during the LPS response ............107 4.4.1. Key genes of the inflammatory response are regulated by TTP and CPEB4 ............................................................................................108 4.4.2. An ARE/CPE score predicts mRNA behaviour during the LPS response .................................................................................................112 14 4.5. Transcriptional control of the LPS response in Cpeb4KO BMDMs ...116 5. CPEB4 function in quiescent BMDMs .............................................................118 6. CPEB4 function in macrophages in vivo .........................................................122 6.1. Myeloid-specificCpeb4 KO mice in homeostasis .....................................124 6.2. Decreased survival of Cpeb4MKO mice to LPS-induced homeostatic shock ......................................................................................................................127 DISCUSSION _________________________________________ 133 1. Inflammation resolution requires CPEB4-mediated translational control ....................................................................................................................135 2. CPEB4, a new player in LPS response ..............................................................136 3. The MAPKs p38 and ERK1/2 regulate CPEB4 levels and activity during the LPS response ......................................................................................137 α 4. Relevance of CPEB4 hyperphosphorylation for LPS response ...................139 5. Closing the circuit: CPEB4 targets are enriched in MAPK pathway-related genes ..........................................................................................140 6. CPEB4 promotes inflammation resolution during the LPS response ..................................................................................................................................142 7. AREs and CPEs define the kinetics of mRNAs during the LPS response .................................................................................................................143 7.1. HuR, TTP and CPEB4 define different mRNA expression waves during the LPS response .............................................................................143 7.2. CPEB4 polyadenylating function stabilizes CPE-containing mRNAs during the LPS response .............................................................145 7.3. The Combinatorial
Recommended publications
  • Genome-Wide Analysis of 5-Hmc in the Peripheral Blood of Systemic Lupus Erythematosus Patients Using an Hmedip-Chip

    Genome-Wide Analysis of 5-Hmc in the Peripheral Blood of Systemic Lupus Erythematosus Patients Using an Hmedip-Chip

    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 35: 1467-1479, 2015 Genome-wide analysis of 5-hmC in the peripheral blood of systemic lupus erythematosus patients using an hMeDIP-chip WEIGUO SUI1*, QIUPEI TAN1*, MING YANG1, QIANG YAN1, HUA LIN1, MINGLIN OU1, WEN XUE1, JIEJING CHEN1, TONGXIANG ZOU1, HUANYUN JING1, LI GUO1, CUIHUI CAO1, YUFENG SUN1, ZHENZHEN CUI1 and YONG DAI2 1Guangxi Key Laboratory of Metabolic Diseases Research, Central Laboratory of Guilin 181st Hospital, Guilin, Guangxi 541002; 2Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, P.R. China Received July 9, 2014; Accepted February 27, 2015 DOI: 10.3892/ijmm.2015.2149 Abstract. Systemic lupus erythematosus (SLE) is a chronic, Introduction potentially fatal systemic autoimmune disease characterized by the production of autoantibodies against a wide range Systemic lupus erythematosus (SLE) is a typical systemic auto- of self-antigens. To investigate the role of the 5-hmC DNA immune disease, involving diffuse connective tissues (1) and modification with regard to the onset of SLE, we compared is characterized by immune inflammation. SLE has a complex the levels 5-hmC between SLE patients and normal controls. pathogenesis (2), involving genetic, immunologic and envi- Whole blood was obtained from patients, and genomic DNA ronmental factors. Thus, it may result in damage to multiple was extracted. Using the hMeDIP-chip analysis and valida- tissues and organs, especially the kidneys (3). SLE arises from tion by quantitative RT-PCR (RT-qPCR), we identified the a combination of heritable and environmental influences. differentially hydroxymethylated regions that are associated Epigenetics, the study of changes in gene expression with SLE.
  • Integrative Analysis of Phenomic, Genomic, and Transcriptomic To

    Integrative Analysis of Phenomic, Genomic, and Transcriptomic To

    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.29.392167; this version posted November 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Integrative Analysis of Phenomic, Genomic, and Transcriptomic to Identify Potential Functional Genes of Yaks in Plain and Plateau Jiabo Wang1,2, §, Jiuqiang Guan3, §, Kangzhu Yixi1,2,Tao Shu1, Zhixin Chai1,2, Jikun Wang1,2, Hui Wang1,2, Zhijuan Wu1,2, Xin Cai1,2, Jincheng Zhong1,2*,Xiaolin Luo3* 1. Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization (Southwest Minzu University), Ministry of Education，Chengdu, Sichuan, China; 2. Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization Key Laboratory of Sichuan Province, Chengdu, Sichuan, China; 3. Sichuan Academy of Grassland Sciences, Chengdu, Sichuan, China; §These authors contributed equally to this work. *Correspondences should be addressed to JZ ([email protected]) and XL ([email protected]) bioRxiv preprint doi: https://doi.org/10.1101/2020.11.29.392167; this version posted November 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Background: The yak is an important source of livelihood for the people living in the Qinghai-Tibet Plateau. Most genetics detection studies have focused on the comparison between different tissues of different breeds, both living in the Plateau and in the plains. The genetic background and complex regulatory relationship have frequently puzzled researchers. In this study, we divided a population of 10 yaks into two subgroups, namely Plateau (living in the Plateau) and Plain (living in the plains).
  • IP6K1 Upregulates the Formation of Processing Bodies by Promoting Proteome Remodeling on the Mrna Cap

    IP6K1 Upregulates the Formation of Processing Bodies by Promoting Proteome Remodeling on the Mrna Cap

    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.199828; this version posted July 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. IP6K1 upregulates the formation of processing bodies by promoting proteome remodeling on the mRNA cap Akruti Shah1,2 and Rashna Bhandari1* 1Laboratory of Cell Signalling, Centre for DNA Fingerprinting and Diagnostics (CDFD), Inner Ring Road, Uppal, Hyderabad 500039, India. 2Graduate studies, Manipal Academy of Higher Education, Manipal 576104, India. *Correspondence to Rashna Bhandari; Email: [email protected] Running title: IP6K1 promotes mRNA turnover to induce P-bodies ORCID IDs Akruti Shah - 0000-0001-9557-4952 Rashna Bhandari - 0000-0003-3101-0204 This PDF file includes: Main Text Figures 1 to 6 Keywords mRNA decay/mRNA metabolism/P-bodies/translation suppression 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.199828; this version posted July 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Inositol hexakisphosphate kinases (IP6Ks) are ubiquitously expressed small molecule kinases that catalyze the conversion of the inositol phosphate IP6 to 5-IP7. IP6Ks have been reported to influence cellular functions by protein-protein interactions independent of their enzymatic activity.
  • Role of DCP1-DCP2 Complex Regulated by Viral and Host Micrornas in DNA Virus Infection T

    Role of DCP1-DCP2 Complex Regulated by Viral and Host Micrornas in DNA Virus Infection T

    Fish and Shellfish Immunology 92 (2019) 21–30 Contents lists available at ScienceDirect Fish and Shellfish Immunology journal homepage: www.elsevier.com/locate/fsi Full length article Role of DCP1-DCP2 complex regulated by viral and host microRNAs in DNA virus infection T ∗ Yuechao Sun, Xiaobo Zhang College of Life Sciences and Laboratory for Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology, Zhejiang University, Hangzhou, 310058, People's Republic of China ARTICLE INFO ABSTRACT Keywords: The DCP1-DCP2 complex can regulate the antiviral immunity of animals by the decapping of retrovirus RNAs DCP1-DCP2 complex and the suppression of RNAi during RNA virus infection. However, the influence of DCP1-DCP2 complex on DNA miRNA virus infection and the regulation of DCP1-DCP2 complex by microRNAs (miRNAs) remain unclear. In this study, DNA virus infection the role of miRNA-regulated DCP1-DCP2 complex in DNA virus infection was characterized. Our results showed that the DCP1-DCP2 complex played a positive role in the infection of white spot syndrome virus (WSSV), a DNA virus of shrimp. In the DCP1-DCP2 complex, the N-terminal regulatory domain of DCP2 was interacted with the EVH1 domain of DCP1. Furthermore, shrimp miRNA miR-87 inhibited WSSV infection by targeting the host DCP2 gene and viral miRNA WSSV-miR-N46 took a negative effect on WSSV replication by targeting the host DCP1 gene. Therefore, our study provided novel insights into the underlying mechanism of DCP1-DCP2 complex and its regulation by miRNAs in virus-host interactions. Importance: During RNA virus infection, the DCP1-DCP2 complex can play important roles in the animal anti- viral immunity by decapping retrovirus RNAs and suppressing RNAi.
  • Atxn2-CAG100-Knockin Mouse Spinal Cord Shows Progressive TDP43

    Atxn2-CAG100-Knockin Mouse Spinal Cord Shows Progressive TDP43

    bioRxiv preprint doi: https://doi.org/10.1101/838177; this version posted November 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression Júlia Canet-Pons1§, Nesli-Ece Sen1,2§, Aleksandar Arsovic1, Luis-Enrique Almaguer-Mederos1,3, Melanie V. Halbach1, Jana Key1,2, Claudia Döring4, Anja Kerksiek5, Gina Picchiarelli6, Raphaelle Cassel6, Frédérique René6, Stéphane Dieterlé6, Nina Hein-Fuchs7, Renate König7, Luc Dupuis6, Dieter Lütjohann5, Suzana Gispert1, Georg Auburger1# 1 Experimental Neurology, Medical Faculty, Goethe University, 60590 Frankfurt am Main, Germany; 2 Faculty of Biosciences, Goethe University, 60438 Frankfurt am Main, Germany; 3 Center for Investigation and Rehabilitation of Hereditary Ataxias (CIRAH), Holguín, Cuba; 4 Dr. Senckenberg Institute of Pathology, Medical Faculty, Goethe University, 60590 Frankfurt am Main, Germany; 5 Institute for Clinical Chemistry and Clinical Pharmacology, Medical Faculty, University Bonn, 53127 Bonn, Nordrhein-Westfalen, Germany; 6 UMRS-1118 INSERM, Faculty of Medicine, University of Strasbourg, 67000 Strasbourg, France; 7 Host-Pathogen Interactions, Paul-Ehrlich-Institute, 63225 Langen, Germany. § Joint first authorship # Correspondence to: [email protected], Tel: +49-69-6301-7428, FAX: +49-69-6301-7142 Acknowledgements: 1 bioRxiv preprint doi: https://doi.org/10.1101/838177; this version posted November 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • Supplementary Table S1. Upregulated Genes Differentially

    Supplementary Table S1. Upregulated Genes Differentially

    Supplementary Table S1. Upregulated genes differentially expressed in athletes (p < 0.05 and 1.3-fold change) Gene Symbol p Value Fold Change 221051_s_at NMRK2 0.01 2.38 236518_at CCDC183 0.00 2.05 218804_at ANO1 0.00 2.05 234675_x_at 0.01 2.02 207076_s_at ASS1 0.00 1.85 209135_at ASPH 0.02 1.81 228434_at BTNL9 0.03 1.81 229985_at BTNL9 0.01 1.79 215795_at MYH7B 0.01 1.78 217979_at TSPAN13 0.01 1.77 230992_at BTNL9 0.01 1.75 226884_at LRRN1 0.03 1.74 220039_s_at CDKAL1 0.01 1.73 236520_at 0.02 1.72 219895_at TMEM255A 0.04 1.72 201030_x_at LDHB 0.00 1.69 233824_at 0.00 1.69 232257_s_at 0.05 1.67 236359_at SCN4B 0.04 1.64 242868_at 0.00 1.63 1557286_at 0.01 1.63 202780_at OXCT1 0.01 1.63 1556542_a_at 0.04 1.63 209992_at PFKFB2 0.04 1.63 205247_at NOTCH4 0.01 1.62 1554182_at TRIM73///TRIM74 0.00 1.61 232892_at MIR1-1HG 0.02 1.61 204726_at CDH13 0.01 1.6 1561167_at 0.01 1.6 1565821_at 0.01 1.6 210169_at SEC14L5 0.01 1.6 236963_at 0.02 1.6 1552880_at SEC16B 0.02 1.6 235228_at CCDC85A 0.02 1.6 1568623_a_at SLC35E4 0.00 1.59 204844_at ENPEP 0.00 1.59 1552256_a_at SCARB1 0.02 1.59 1557283_a_at ZNF519 0.02 1.59 1557293_at LINC00969 0.03 1.59 231644_at 0.01 1.58 228115_at GAREM1 0.01 1.58 223687_s_at LY6K 0.02 1.58 231779_at IRAK2 0.03 1.58 243332_at LOC105379610 0.04 1.58 232118_at 0.01 1.57 203423_at RBP1 0.02 1.57 AMY1A///AMY1B///AMY1C///AMY2A///AMY2B// 208498_s_at 0.03 1.57 /AMYP1 237154_at LOC101930114 0.00 1.56 1559691_at 0.01 1.56 243481_at RHOJ 0.03 1.56 238834_at MYLK3 0.01 1.55 213438_at NFASC 0.02 1.55 242290_at TACC1 0.04 1.55 ANKRD20A1///ANKRD20A12P///ANKRD20A2///
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Supplementary Materials

    Supplementary Materials

    1 Supplementary Materials: Supplemental Figure 1. Gene expression profiles of kidneys in the Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice. (A) A heat map of microarray data show the genes that significantly changed up to 2 fold compared between Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice (N=4 mice per group; p<0.05). Data show in log2 (sample/wild-type). 2 Supplemental Figure 2. Sting signaling is essential for immuno-phenotypes of the Fcgr2b-/-lupus mice. (A-C) Flow cytometry analysis of splenocytes isolated from wild-type, Fcgr2b-/- and Fcgr2b-/-. Stinggt/gt mice at the age of 6-7 months (N= 13-14 per group). Data shown in the percentage of (A) CD4+ ICOS+ cells, (B) B220+ I-Ab+ cells and (C) CD138+ cells. Data show as mean ± SEM (*p < 0.05, **p<0.01 and ***p<0.001). 3 Supplemental Figure 3. Phenotypes of Sting activated dendritic cells. (A) Representative of western blot analysis from immunoprecipitation with Sting of Fcgr2b-/- mice (N= 4). The band was shown in STING protein of activated BMDC with DMXAA at 0, 3 and 6 hr. and phosphorylation of STING at Ser357. (B) Mass spectra of phosphorylation of STING at Ser357 of activated BMDC from Fcgr2b-/- mice after stimulated with DMXAA for 3 hour and followed by immunoprecipitation with STING. (C) Sting-activated BMDC were co-cultured with LYN inhibitor PP2 and analyzed by flow cytometry, which showed the mean fluorescence intensity (MFI) of IAb expressing DC (N = 3 mice per group). 4 Supplemental Table 1. Lists of up and down of regulated proteins Accession No.
  • Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response

    Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response

    Research Article Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response Joung Hyuck Joo,1 Grace Liao,1 Jennifer B. Collins,2 Sherry F. Grissom,2 and Anton M. Jetten1 1Cell Biology Section, LRB, and 2Microarray Group, Division of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina Abstract range of fruits and vegetables (9, 10). Each isoprenoid has been Farnesol (FOH) and other isoprenoid alcohols induce apopto- shown to inhibit proliferation and induce apoptosis in a number of sis in various carcinoma cells and inhibit tumorigenesis in neoplastic cell lines from different origins (4, 11–14). In addition, in vivo these isoprenoids have been reported to be effective in chemo- several models. However, the mechanisms by which in vivo they mediate their effects are not yet fully understood. In this prevention and chemotherapy in various cancer models study, we show that FOH is an effective inducer of apoptosis in (10, 12, 15, 16). FOH has been reported to exhibit chemopreventive several lung carcinoma cells, including H460. This induction is effects in colon and pancreas carcinogenesis in rats (9, 17) whereas associated with activation of several caspases and cleavage of phase I and II clinical trials have indicated therapeutic potential poly(ADP-ribose) polymerase (PARP). To obtain insight into for POH (16, 18). The mechanisms by which these isoprenoids induce these effects are not yet fully understood. Isoprenoids have the mechanism involved in FOH-induced apoptosis, we compared the gene expression profiles of FOH-treated and been reported to inhibit posttranslational protein prenylation (19) control H460 cells by microarray analysis.
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation

    4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation

    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
  • Multi-Targeted Mechanisms Underlying the Endothelial Protective Effects of the Diabetic-Safe Sweetener Erythritol

    Multi-Targeted Mechanisms Underlying the Endothelial Protective Effects of the Diabetic-Safe Sweetener Erythritol

    Multi-Targeted Mechanisms Underlying the Endothelial Protective Effects of the Diabetic-Safe Sweetener Erythritol Danie¨lle M. P. H. J. Boesten1*., Alvin Berger2.¤, Peter de Cock3, Hua Dong4, Bruce D. Hammock4, Gertjan J. M. den Hartog1, Aalt Bast1 1 Department of Toxicology, Maastricht University, Maastricht, The Netherlands, 2 Global Food Research, Cargill, Wayzata, Minnesota, United States of America, 3 Cargill RandD Center Europe, Vilvoorde, Belgium, 4 Department of Entomology and UCD Comprehensive Cancer Center, University of California Davis, Davis, California, United States of America Abstract Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets.
  • Eif2b Is a Decameric Guanine Nucleotide Exchange Factor with a G2e2 Tetrameric Core

    Eif2b Is a Decameric Guanine Nucleotide Exchange Factor with a G2e2 Tetrameric Core

    ARTICLE Received 19 Feb 2014 | Accepted 15 Apr 2014 | Published 23 May 2014 DOI: 10.1038/ncomms4902 OPEN eIF2B is a decameric guanine nucleotide exchange factor with a g2e2 tetrameric core Yuliya Gordiyenko1,2,*, Carla Schmidt1,*, Martin D. Jennings3, Dijana Matak-Vinkovic4, Graham D. Pavitt3 & Carol V. Robinson1 eIF2B facilitates and controls protein synthesis in eukaryotes by mediating guanine nucleotide exchange on its partner eIF2. We combined mass spectrometry (MS) with chemical cross- linking, surface accessibility measurements and homology modelling to define subunit stoichiometry and interactions within eIF2B and eIF2. Although it is generally accepted that eIF2B is a pentamer of five non-identical subunits (a–e), here we show that eIF2B is a decamer. MS and cross-linking of eIF2B complexes allows us to propose a model for the subunit arrangements within eIF2B where the subunit assembly occurs through catalytic g- and e-subunits, with regulatory subunits arranged in asymmetric trimers associated with the core. Cross-links between eIF2 and eIF2B allow modelling of interactions that contribute to nucleotide exchange and its control by eIF2 phosphorylation. Finally, we identify that GTP binds to eIF2Bg, prompting us to propose a multi-step mechanism for nucleotide exchange. 1 Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, UK. 2 MRC Laboratory of Molecular Biology, University of Cambridge, Francis Crick Avenue, Cambridge CB2 0QH, UK. 3 Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK. 4 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.